Methotrexate associates with ischemic cardiovascular risk reduction in males but not females: a transatlantic cardiovascular consortium for people with rheumatoid arthritis observational study

By sjmartinez • April 19, 2025

Karpouzas GA, Ormseth SR, Van Riel P, Myasoedova E, Gonzalez-Gay MA, Corrales A, Rantapaa-Dahlqvist S, Sfikakis P, Dessein P, Hitchon CA, Pascual-Ramos V, Yanez IC, Colunga-Pedraza IJ, Galarza-Delgado DA, Azpiri-Lopez J, Semb AG, Misra DP, Kitas GD, Hauge EM. Methotrexate associates with ischemic cardiovascular risk reduction in males but not females: a transatlantic cardiovascular consortium for people with rheumatoid arthritis observational study. Rheumatol Int. 2025 Apr 18;45(5):106. doi: 10.1007/s00296-025-05838-y. PMID: 40249410.

Tags: cardiovascular disease, Harbor UCLA, methotrexate, Publications, Rheumatoid arthritis, Rheumatology, sex

International Society for Peritoneal Dialysis Journal Club: Bridging the Gap between Trainee Education and Home Dialysis Demand

El Shamy O, Shah AD, Salani M, Rivara MB, Teitelbaum I, Quinn R, Shen JI, Golper T. International Society for Peritoneal Dialysis Journal Club: Bridging[...]

TREM-1 as a novel immunotherapeutic target to treat pancreatic ductal adenocarcinoma

Gross L, Mutisheva I, Hillen H, Robatel S, Wartenberg M, Ma F, Bäriswyl L, Lee DJ, Modlin RL, Z'graggen K, Schenk M. TREM-1 as a[...]

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Abatacept

Nadig N, Bhimraj A, Cawcutt K, Chiotos K, Dzierba AL, Kim AY, Martin GS, Pearson JC, Shumaker AH, Baden LR, Bedimo R, Cheng VC, Chew[...]